Quinn Opportunity Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Quinn Opportunity Partners’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-227,427	Closed	-$917K	–	338
2025 Q2	$917K	Hold	227,427	–	–	0.08%	193
2025 Q1	$621K	Hold	227,427	–	–	0.04%	252
2024 Q4	$967K	Hold	227,427	–	–	0.07%	206
2024 Q3	$669K	Hold	227,427	–	–	0.06%	172
2024 Q2	$791K	Hold	227,427	–	–	0.09%	144
2024 Q1	$648K	Buy	227,427 +56,707	+33%	+$175K	0.07%	159
2023 Q4	$603K	Hold	170,720	–	–	0.06%	148
2023 Q3	$442K	Hold	170,720	–	–	0.06%	163
2023 Q2	$673K	Hold	170,720	–	–	0.09%	128
2023 Q1	$577K	Hold	170,720	–	–	0.06%	160
2022 Q4	$611K	Hold	170,720	–	–	0.07%	123
2022 Q3	$688K	Sell	170,720 -22,341	-12%	-$115K	0.08%	116
2022 Q2	$861K	Sell	193,061 -123,516	-39%	-$891K	0.07%	128
2022 Q1	$2.69M	Hold	316,577	–	–	0.12%	82
2021 Q4	$2.79M	Buy	+316,577	New	+$3.01M	0.17%	98

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quinn Opportunity Partners's SRTA Position: Q3 2025 in Review

Quinn Opportunity Partners sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 227,427 shares — an estimated $917K sold.

Quinn Opportunity Partners first reported a position in SRTA in Q4 2021 and held it in 15 quarters. The position peaked at $2.79M in Q4 2021. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

Quinn Opportunity Partners reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
Quinn Opportunity Partners sold 227,427 Strata Critical Medical Inc shares in Q3 2025, an estimated $917K.
Quinn Opportunity Partners first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 15 quarters.
Quinn Opportunity Partners's Strata Critical Medical Inc position peaked at $2.79M in Q4 2021.
137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Quinn Opportunity Partners's 13F filing for Q3 2025, filed 13 Nov 2025.